FREIER SUSAN M has a total of 30 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Israel. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are BENNETT C FRANK, NEUROPROGEN GMBH LEIPZIG and NAVAL MEDICAL RES CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 13 | |
#3 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change mitigation in goods production | |
#5 | Sugars | |
#6 | Enzymes | |
#7 | Measuring microorganism processes | |
#8 | Peptides | |
#9 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Freier Susan M | 30 |
#2 | Monia Brett P | 11 |
#3 | Wyatt Jacqueline R | 6 |
#4 | Zhang Hong | 5 |
#5 | Bhanot Sanjay | 4 |
#6 | Mckay Robert | 4 |
#7 | Watt Andrew T | 4 |
#8 | Zhao Chenguang | 4 |
#9 | Tribble Diane | 3 |
#10 | Siwkowski Andrew M | 3 |
Publication | Filing date | Title |
---|---|---|
US2009318536A1 | Methods for treating hypercholesterolemia | |
US2005208532A1 | Compositions and their uses directed to signal transducers | |
WO2004003134A2 | Antisense inhibition via rnase h-independent reduction in mrna |